Sesen Bio Inc (SESN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Stephen Allen Hurly
Employees:
24
245 FIRST STREET, SUITE 1800, CAMBRIDGE, MA 02142
617-444-8550

Eleven Biotherapeutics, Inc. is a preclinical stage biopharmaceutical company engages in medical development. It involves in the management of proprietary protein engineering platform called AMP-Rx for the development and discovery of protein therapeutics to treat diseases of the eye. Through therapeutic approach, it focuses on structural biology of cytokines to design and generate product candidate called EBI-031, that targets Diabetic Macular Edema diseases. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.

Data derived from most recent annual or quarterly report
Market Cap 163.161 Million Shares Outstanding199.464 Million Avg 30-day Volume 6.781 Million
P/E Ratio2.2111 Dividend Yield0.0 EPS-0.5
Price to Revenue5.4069 Debt to Equity0.0 EBITDA45.873 Million
Price to Book Value0.6957 Operating Margin206.1572 Enterprise Value-49.573 Million
Current Ratio21.317 EPS Growth1.412 Quick Ratio20.279
1 Yr BETA 1.2056 52-week High/Low 6.04 / 0.37 Profit Margin244.5309
Operating Cash Flow Growth-6.8563 Altman Z-Score1.0769 Free Cash Flow to Firm 107.701 Million
Earnings Report2022-08-08
View SEC Filings from SESN instead.

View recent insider trading info

Funds Holding SESN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SESN BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-23:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-06-17:
    Item 8.01: Other Events
  • 8-K: filed on 2022-05-20:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2022-05-16:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2022-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-30:
    Item 8.01: Other Events
  • 8-K: filed on 2022-03-16:
    Item 8.01: Other Events
  • 8-K: filed on 2022-02-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-25:
    Item 8.01: Other Events
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HONIG PETER

    • Director
    105,000 2022-06-22 3

    DUKER JAY S.

    • Director
    105,000 2022-06-22 1

    BOURDOW CARRIE L.

    • Director
    105,000 2022-06-22 1

    KEYES JASON A

    • Director
    105,000 2022-06-22 1

    JEWETT MICHAEL A. S.

    • Director
    105,000 2022-06-22 3

    RYU ELLY PRINCIPAL ACCOUNTING OFFICER

    • Officer
    95,500 2022-06-01 3

    SULLIVAN MARK GENERAL COUNSEL & SECRETARY

    • Officer
    339,525 2022-02-18 1

    CANNELL THOMAS R PRESIDENT AND CEO

    • Officer
    • Director
    606,800 2022-02-18 1

    FORBES MONICA CHIEF FINANCIAL OFFICER

    • Officer
    542,250 2022-02-18 1

    MACDONALD GLEN C CHIEF TECHNOLOGY OFFICER

    • Officer
    308,925 2022-02-18 1

    ROSALES MINORI CHIEF DEVELOPMENT OFFICER

    • Officer
    0 2022-01-24 2

    DRAKE PATRICIA M. CHIEF COMMERCIAL OFFICER

    • Officer
    1,000,000 2021-06-01 0

    HENDERSON JANE

    • Director
    92,500 2021-05-03 0

    ANDERSON KIRSTIN PRINCIPAL ACCOUNTING OFFICER

    • Officer
    50,000 2021-02-19 0

    LYNCH DANIEL

    • Director
    0 2019-06-19 0

    DAN LESLIE

    • Director
    0 2019-06-19 0

    DIXON WENDY L

    • Director
    0 2019-06-19 0

    FITZGERALD RICHARD F CHIEF FINANCIAL OFFICER

    • Officer
    0 2019-02-21 0

    KIM DENNIS CHIEF MEDICAL OFFICER

    • Officer
    0 2018-12-03 0

    HURLY STEPHEN A PRESIDENT AND CEO

    • Officer
    • Director
    0 2018-06-12 0

    CHANEY PAUL G

    • Director
    0 2018-06-12 0

    CELNIKER ABBIE

    • Director
    0 2018-06-12 0

    GERTZ BARRY

    • Director
    0 2017-05-19 0

    MCCABE JOHN J CHIEF FINANCIAL OFFICER

    • Officer
    0 2017-04-03 0

    DECILLIS ARTHUR CHIEF MEDICAL OFFICER

    • Officer
    0 2017-04-03 0

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES FUND 2007, L.P.

    FLAGSHIP VENTURES FUND IV-RX, L.P.

    FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    AFEYAN NOUBAR

    KANIA EDWIN M JR

    • 10% Owner
    No longer subject to file 2016-09-22 0

    CLAIRMARK INVESTMENTS LTD.

    • 10% Owner
    3,582,328 2016-09-20 0

    TUBRIDY KAREN L CHIEF DEVELOPMENT OFFICER

    • Officer
    0 2016-07-09 0

    BOXER CAPITAL, LLC

    BOXER ASSET MANAGEMENT INC.

    LEWIS JOSEPH

    MVA INVESTORS, LLC

    • 10% Owner
    No longer subject to file 2016-06-13 0

    BERRY DAVID A

    • Director
    0 2016-06-08 0

    PFEFFER CARY

    • Director
    0 2016-06-08 0

    FURFINE ERIC STEVEN CHIEF SCIENTIFIC OFFICER

    • Officer
    34,648 2015-12-28 0

    JAFCO SUPER V3 INVESTMENT LIMITED PARTNERSHIP

    • 10% Owner
    No longer subject to file 2015-05-08 0

    PERRY GREGORY D CHIEF FINANCIAL AND BUSINESS

    • Officer
    0 2015-02-26 0

    LEVIN MARK J

    • Director
    0 2014-03-20 0

    AFEYAN NOUBAR

    • Director
    0 2014-03-20 0

    THIRD ROCK VENTURES LP

    THIRD ROCK VENTURES GP, L.P.

    TRV GP, LLC

    STARR KEVIN P

    TEPPER ROBERT I

    LEVIN MARK J

    • Director
    • 10% Owner
    4,841,591 2014-02-11 0

    STARR KEVIN P

    TEPPER ROBERT I

    • 10% Owner
    330,708 2014-02-05 0

    THIRD ROCK VENTURES LP

    THIRD ROCK VENTURES GP, L.P.

    TRV GP, LLC

    • 10% Owner
    330,708 2014-02-05 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BOURDOW CARRIE L. - Director

    2022-06-24 18:28:11 -0400 2022-06-22 A 40,000 a 40,000 direct

    BOURDOW CARRIE L. - Director

    2022-06-24 18:28:11 -0400 2022-06-22 A 65,000 a 65,000 direct

    KEYES JASON A - Director

    2022-06-24 18:29:19 -0400 2022-06-22 A 40,000 a 40,000 direct

    KEYES JASON A - Director

    2022-06-24 18:29:19 -0400 2022-06-22 A 65,000 a 65,000 direct

    HONIG PETER - Director

    2022-06-24 18:31:43 -0400 2022-06-22 A 40,000 a 40,000 direct

    HONIG PETER - Director

    2022-06-24 18:31:43 -0400 2022-06-22 A 65,000 a 65,000 direct

    JEWETT MICHAEL A. S. - Director

    2022-06-24 18:30:28 -0400 2022-06-22 A 40,000 a 40,000 direct

    JEWETT MICHAEL A. S. - Director

    2022-06-24 18:30:28 -0400 2022-06-22 A 65,000 a 65,000 direct

    DUKER JAY S. - Director

    2022-06-24 18:37:25 -0400 2022-06-22 A 40,000 a 40,000 direct

    DUKER JAY S. - Director

    2022-06-24 18:37:25 -0400 2022-06-22 A 65,000 a 65,000 direct

    RYU ELLY - Officer PRINCIPAL ACCOUNTING OFFICER

    2022-06-03 19:22:36 -0400 2022-06-01 A 95,500 a 95,500 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SESEN BIO INC SESN 2022-06-24 22:15:03 UTC -3.0241 4.5941 10000
    SESEN BIO INC SESN 2022-06-24 21:45:03 UTC -3.0241 4.5941 10000
    SESEN BIO INC SESN 2022-06-24 21:15:04 UTC -3.0241 4.5941 10000
    SESEN BIO INC SESN 2022-06-24 20:45:03 UTC -3.1887 4.7587 10000
    SESEN BIO INC SESN 2022-06-24 20:15:03 UTC -3.1887 4.7587 10000
    SESEN BIO INC SESN 2022-06-24 19:45:03 UTC -3.1887 4.7587 10000
    SESEN BIO INC SESN 2022-06-24 19:15:03 UTC -3.1887 4.7587 10000
    SESEN BIO INC SESN 2022-06-24 18:45:03 UTC -3.5367 5.1067 10000
    SESEN BIO INC SESN 2022-06-24 18:15:04 UTC -3.5367 5.1067 10000
    SESEN BIO INC SESN 2022-06-24 17:45:03 UTC -3.5367 5.1067 10000
    SESEN BIO INC SESN 2022-06-24 17:15:03 UTC -3.5367 5.1067 10000
    SESEN BIO INC SESN 2022-06-24 16:45:03 UTC -3.5367 5.1067 10000
    SESEN BIO INC SESN 2022-06-24 16:15:03 UTC -3.5367 5.1067 10000
    SESEN BIO INC SESN 2022-06-24 15:45:03 UTC -3.5367 5.1067 10000
    SESEN BIO INC SESN 2022-06-24 15:15:03 UTC -3.5367 5.1067 10000
    SESEN BIO INC SESN 2022-06-24 14:45:03 UTC -2.4785 4.0485 10000
    SESEN BIO INC SESN 2022-06-24 14:15:03 UTC -2.4785 4.0485 10000
    SESEN BIO INC SESN 2022-06-24 13:45:03 UTC -2.4785 4.0485 10000
    SESEN BIO INC SESN 2022-06-24 13:15:03 UTC -2.4785 4.0485 4000
    SESEN BIO INC SESN 2022-06-24 12:45:03 UTC -2.4785 4.0485 4000

    Current Active Short Positions

    Get more info on our International short position coverage here

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund SESN -268.0 shares, $-161.52 2022-03-31 N-PORT
    Henderson Global Investors Limited Sesen Bio, Inc 0.51% 2021-10-20 GERMANY

    Short Position History (International Only)

    Holder Net Short Position Position Date Origin

    Elevate your investments